R T van Domburg

Author PubWeight™ 67.78‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Costs and effects of long-term oral anticoagulant treatment after myocardial infarction. JAMA 1995 2.20
2 Platelet GP IIb/IIIa receptor blockers for failed thrombolysis in acute myocardial infarction, alone or as adjunct to other rescue therapies; single centre retrospective analysis of 548 consecutive patients with acute myocardial infarction. Eur Heart J 2002 1.99
3 Psychosocial functioning of the adult with congenital heart disease: a 20-33 years follow-up. Eur Heart J 2003 1.65
4 Dobutamine-induced hypoperfusion without transient wall motion abnormalities: less severe ischemia or less severe stress? J Am Coll Cardiol 1996 1.63
5 Safety and prognostic value of early dobutamine-atropine stress echocardiography in patients with spontaneous chest pain and a non-diagnostic electrocardiogram. Eur Heart J 2000 1.55
6 COPD and cancer mortality: the influence of statins. Thorax 2009 1.53
7 Dobutamine-atropine stress myocardial perfusion SPECT imaging in the diagnosis of graft stenosis after coronary artery bypass grafting. J Nucl Cardiol 1999 1.44
8 T wave normalization during dobutamine stress testing in patients with non-Q wave myocardial infarction. A marker of myocardial ischaemia? Eur Heart J 1996 1.42
9 Prognostic value of dobutamine-atropine stress technetium-99m sestamibi perfusion scintigraphy in patients with chest pain. J Am Coll Cardiol 1996 1.40
10 Women fare no worse than men 10 years after attempted coronary angioplasty. Cathet Cardiovasc Diagn 1996 1.39
11 Mortality and repeat interventions up until 20 years after aorto-coronary bypass surgery with saphenous vein grafts. A follow-up study of 1041 patients. Eur Heart J 2000 1.39
12 Reduced positive affect (anhedonia) predicts major clinical events following implantation of coronary-artery stents. J Intern Med 2007 1.10
13 Which patients benefit most from early thrombolytic therapy with intracoronary streptokinase? Circulation 1986 1.08
14 OPTImal CArdiac REhabilitation (OPTICARE) following Acute Coronary Syndromes: Rationale and design of a randomised, controlled trial to investigate the benefits of expanded educational and behavioural intervention programs. Neth Heart J 2013 1.07
15 Sustained benefit at 10-14 years follow-up after thrombolytic therapy in myocardial infarction. Eur Heart J 1999 1.05
16 Evaluation by quantitative 99m-technetium MIBI SPECT and echocardiography of myocardial perfusion and wall motion abnormalities in patients with dobutamine-induced ST-segment elevation. Am J Cardiol 1995 1.00
17 Cardiac imaging for risk stratification with dobutamine-atropine stress testing in patients with chest pain. Echocardiography, perfusion scintigraphy, or both? Circulation 1997 0.99
18 The influence of aging on the prognostic value of the revised cardiac risk index for postoperative cardiac complications in vascular surgery patients. Eur J Vasc Endovasc Surg 2007 0.99
19 Clinical utility and cost effectiveness of a personal ultrasound imager for cardiac evaluation during consultation rounds in patients with suspected cardiac disease. Heart 2003 0.99
20 Heparin-coated bypass circuits: effects on inflammatory response in pediatric cardiac operations. Ann Thorac Surg 1998 0.95
21 First-line evaluation of coronary artery disease with coronary calcium scanning or exercise electrocardiography. Int J Cardiol 2011 0.95
22 Remodeling of atherosclerotic coronary arteries varies in relation to location and composition of plaque. Am J Cardiol 1999 0.95
23 Safety and feasibility of dobutamine-atropine stress echocardiography for the diagnosis of coronary artery disease in diabetic patients unable to perform an exercise stress test. Diabetes Care 1998 0.92
24 Encouraging survival rates in patients with acute myocardial infarction treated with an intra-aortic balloon pump. Neth Heart J 2011 0.89
25 Health care utilisation after defibrillator implantation for primary prevention according to the guidelines in 2 Dutch academic medical centres. Neth Heart J 2011 0.89
26 Comparison of dobutamine stress echocardiography and technetium-99m sestamibi single-photon emission tomography for the diagnosis of coronary artery disease in hypertensive patients with and without left ventricular hypertrophy. Eur J Nucl Med 1998 0.89
27 Accuracy of exercise stress technetium 99m sestamibi SPECT imaging in the evaluation of the extent and location of coronary artery disease in patients with an earlier myocardial infarction. J Nucl Cardiol 2001 0.87
28 Relation between contractile response of akinetic segments during dobutamine stress echocardiography and myocardial ischemia assessed by simultaneous thallium-201 single-photon emission computed tomography. Am J Cardiol 1996 0.86
29 Significance of resting wall motion abnormalities in 2-dimensional echocardiography in patients without previous myocardial infarction referred for pharmacologic stress testing. J Am Soc Echocardiogr 2000 0.86
30 Measurements and day-to-day variabilities of left ventricular volumes and ejection fraction by three-dimensional echocardiography and comparison with magnetic resonance imaging. Am J Cardiol 1998 0.86
31 Low-dose dobutamine echocardiography and rest-redistribution thallium-201 tomography in the assessment of spontaneous recovery of left ventricular function after recent myocardial infarction. Am Heart J 1996 0.85
32 Routine sirolimus eluting stent implantation for unselected in-stent restenosis: insights from the rapamycin eluting stent evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry. Heart 2004 0.85
33 Medical predictors for psychopathology in adults with operated congenital heart disease. Eur Heart J 2004 0.84
34 Long-term clinical outcome after stent implantation in saphenous vein grafts. J Am Coll Cardiol 1996 0.84
35 Impact of severity of coronary artery stenosis and the collateral circulation on the functional outcome of dyssynergic myocardium after revascularization in patients with healed myocardial infarction and chronic left ventricular dysfunction. Am J Cardiol 1997 0.83
36 Impact of hypertension on the accuracy of exercise stress myocardial perfusion imaging for the diagnosis of coronary artery disease. Heart 2001 0.83
37 Dobutamine 99Tcm-MIBI SPET myocardial perfusion scintigraphy in the prediction of restenosis after percutaneous transluminal coronary angioplasty in patients unable to perform an exercise stress test. Nucl Med Commun 1997 0.83
38 Safety and feasibility of dobutamine-atropine stress testing in hypertensive patients. Hypertension 1997 0.83
39 Clinical outcome 10 years after attempted percutaneous transluminal coronary angioplasty in 856 patients. J Am Coll Cardiol 1996 0.82
40 Myocardial perfusion abnormalities in treated hypertensive patients without known coronary artery disease. J Hypertens 1999 0.82
41 Relation between the extent of coronary artery disease and tachyarrhythmias during dobutamine stress echocardiography. Am J Cardiol 1999 0.82
42 Accuracy of dobutamine tetrofosmin myocardial perfusion imaging for the noninvasive diagnosis of transplant coronary artery stenosis. J Heart Lung Transplant 2000 0.81
43 Safety, hemodynamic profile, and feasibility of dobutamine stress technetium myocardial perfusion single-photon emission CT imaging for evaluation of coronary artery disease in the elderly. Chest 2000 0.81
44 Akinesis becoming dyskinesis during dobutamine stress echocardiography. A predictor of poor functional recovery after surgical revascularization. Chest 1996 0.81
45 Optimal criteria for the diagnosis of coronary artery disease by dobutamine stress echocardiography. Am J Cardiol 1998 0.81
46 The functional significance of chronotropic incompetence during dobutamine stress test. Heart 1999 0.81
47 Long term outcome in patients with silent versus symptomatic ischaemia during dobutamine stress echocardiography. Heart 2005 0.81
48 Comparison of dobutamine stress echocardiography and 99m-technetium sestamibi SPECT myocardial perfusion scintigraphy for predicting extent of coronary artery disease in patients with healed myocardial infarction. Am J Cardiol 1997 0.81
49 Prognostic significance of normal dobutamine-atropine stress sestamibi scintigraphy in women with chest pain. Am J Cardiol 1996 0.81
50 Long-term outcome of the unrestricted use of everolimus-eluting stents compared to sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients: the Bern-Rotterdam diabetes cohort study. Int J Cardiol 2013 0.81
51 Results of primary two-patch repair of complete atrioventricular septal defect. Eur J Cardiothorac Surg 2000 0.81
52 Computer-generated discharge letters in the coronary care unit. Med Inform (Lond) 1985 0.80
53 Compliance with the medical regimen and partner's quality of life after heart transplantation. Qual Life Res 1993 0.80
54 The prognostic value of impaired walking distance on long-term outcome in patients with known or suspected peripheral arterial disease. Eur J Vasc Endovasc Surg 2009 0.80
55 Noninvasive diagnosis of coronary artery stenosis in women with limited exercise capacity: comparison of dobutamine stress echocardiography and 99mTc sestamibi single-photon emission CT. Chest 1998 0.80
56 The significance of stress-induced ST segment depression in patients with inferior Q wave myocardial infarction. J Am Coll Cardiol 1999 0.78
57 Prognostic value of dobutamine stress echocardiography in patients with previous coronary revascularisation. Heart 2004 0.78
58 Efficacy of long-term anticoagulant treatment in subgroups of patients after myocardial infarction. Br Heart J 1995 0.78
59 Assessment of patients after coronary artery bypass grafting by dobutamine stress echocardiography. Am J Cardiol 1996 0.77
60 Effect of coronary artery bypass surgery on myocardial perfusion and ejection fraction response to inotropic stimulation in patients without improvement in resting ejection fraction. Am J Cardiol 2000 0.77
61 Beta-blockers improve outcomes in kidney disease patients having noncardiac vascular surgery. Kidney Int 2007 0.77
62 Relation among exercise-induced ventricular arrhythmias, myocardial ischemia, and viability late after acute myocardial infarction. Am J Cardiol 2000 0.77
63 Prognostic significance of nonfatal myocardial reinfarction in survivors of a first infarction. Neth Heart J 2001 0.77
64 The grade of worsening of regional function during dobutamine stress echocardiography predicts the extent of myocardial perfusion abnormalities. Heart 2000 0.77
65 Safety of dobutamine-atropine stress myocardial perfusion scintigraphy. J Nucl Med 1998 0.77
66 Methionine loading does not enhance the predictive value of homocysteine serum testing for all-cause mortality or major adverse cardiac events. Intern Med J 2008 0.76
67 Gender differences in the accuracy of dobutamine stress echocardiography for the diagnosis of coronary artery disease. Am J Cardiol 1997 0.76
68 Development of the Rotterdam Quality of Life Questionnaire for Heart Transplant Recipients. Neth Heart J 2003 0.76
69 Predicting non-adherence in patients with familial hypercholesterolemia. Eur J Clin Pharmacol 2014 0.76
70 Long-term cardiac outcome in high-risk patients undergoing elective endovascular or open infrarenal abdominal aortic aneurysm repair. Eur J Vasc Endovasc Surg 2008 0.76
71 Dobutamine technetium-99m tetrofosmin SPECT imaging for the diagnosis of coronary artery disease in patients with limited exercise capacity. J Nucl Cardiol 2000 0.76
72 Accuracy of dobutamine technetium 99m sestamibi SPECT imaging for the diagnosis of single-vessel coronary artery disease: comparison with echocardiography. Am Heart J 2000 0.75
73 Long-term mortality of chest pain patients managed according to a decision scheme that aims to avoid inappropriate hospitalisations. Neth Heart J 2003 0.75
74 Characteristics and prognosis of non-participants of a multi-centre trial of long-term anticoagulant treatment after myocardial infarction. Int J Cardiol 1995 0.75
75 Dobutamine stress thallium-201 single-photon emission tomography versus echocardiography for evaluation of the extent and location of coronary artery disease late after myocardial infarction. Eur J Nucl Med 1999 0.75
76 Relation between ST segment elevation during dobutamine stress test and myocardial viability after a recent myocardial infarction. Heart 1997 0.75
77 Impaired systolic blood pressure response to dobutamine stress testing: a marker of more severe functional abnormalities in patients with myocardial infarction. J Am Soc Echocardiogr 1998 0.75
78 Impact of heart transplantation on the safety and feasibility of the dobutamine stress test. J Heart Lung Transplant 2001 0.75
79 Gender differences in the relation between ST-T-wave abnormalities at baseline electrocardiogram and stress myocardial perfusion abnormalities in patients with suspected coronary artery disease. Am J Cardiol 1999 0.75
80 Prognostic significance of systolic blood pressure changes during dobutamine-atropine stress technetium-99m sestamibi perfusion scintigraphy in patients with chest pain and known or suspected coronary artery disease. Am J Cardiol 1997 0.75
81 Echocardiographic studies of dobutamine-induced ST-segment elevation before and after coronary artery bypass grafting in patients with old Q-wave myocardial infarction. J Am Soc Echocardiogr 1999 0.75
82 Stress-induced left ventricular dysfunction in silent and symptomatic myocardial ischemia during dobutamine stress test. Am J Cardiol 1995 0.75
83 Dobutamine thallium-201 SPECT imaging for assessment of peri-infarction and remote myocardial ischemia. J Nucl Med 1996 0.75
84 Prognostic implications of a normal dobutamine-atropine stress echocardiogram in patients with chest pain. J Am Soc Echocardiogr 1998 0.75
85 Altered myocardial perfusion during dobutamine stress testing in silent versus symptomatic myocardial ischaemia assessed by quantitative MIBI SPET imaging. Eur J Nucl Med 1996 0.75
86 Relation between exercise-induced ventricular arrhythmias and myocardial perfusion abnormalities in patients with intermediate pretest probability of coronary artery disease. Eur J Nucl Med 2000 0.75